Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Published

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Investor Contact Ashley Kaplowitz 786-252-1419 ashley.kaplowitz@sagerx.com Media Contact Matthew Henson 917-930-7147 matthew.henson@sagerx.com

Source: Sage Therapeutics, Inc.

In This Story

SAGE